ARTICLE | Company News
Clementia, Roche deal
January 13, 2014 8:00 AM UTC
Clementia said in April 2013 it received from Roche exclusive, worldwide rights to palovarotene ( RG667) for an undisclosed upfront payment. Roche is also eligible for milestones and royalties. Clemen...